Since it became evident that only 15%-20% of the familial risk for BC/OC can be explained by mutations in the major breast cancer-susceptibility genes BRCA1 and BRCA2 [1], the search for additional BC/OC susceptibility loci has been pursued. This evidence concerns the gene BRCA1 and breast carcinoma.